Edition:
United Kingdom

Corbus Pharmaceuticals Holdings Inc (CRBP.OQ)

CRBP.OQ on NASDAQ Stock Exchange Global Market

6.80USD
8:59pm GMT
Change (% chg)

$-0.35 (-4.90%)
Prev Close
$7.15
Open
$7.20
Day's High
$7.20
Day's Low
$6.78
Volume
162,865
Avg. Vol
121,614
52-wk High
$10.50
52-wk Low
$5.35

Select another date:

Wed, Nov 8 2017

BRIEF-Corbus Pharmaceuticals Q3 loss per share $0.14

* Corbus Pharmaceuticals reports 2017 third quarter financial results and highlights recent corporate and clinical advancements

BRIEF-Corbus Pharma reports improvement in skin conditions in a mid-stage study

* Corbus Pharmaceuticals reports significant improvement in mRSS and other clinical outcomes at 28-weeks in systemic sclerosis open-label extension of phase 2 study

BRIEF-Corbus Pharma prices underwritten public offering of common stock

* Corbus Pharmaceuticals Holdings, Inc. prices underwritten public offering of common stock

BRIEF-Corbus Pharmaceuticals Holdings announces proposed public offering of common stock

* Corbus Pharmaceuticals Holdings Inc announces proposed public offering of common stock

BRIEF-Corbus Pharma's inflammatory disease drug succeeds mid-stage study

* Corbus Pharmaceuticals reports positive topline results from phase 2 study in rare autoimmune disease dermatomyositis

BRIEF-Corbus Pharmaceuticals Holdings reports Q2 loss per share $0.15

* Corbus Pharmaceuticals reports 2017 second quarter financial results and provides business update

Select another date: